Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Upadacitinib”

127 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 127 results

Not applicableStudy completedNCT07472309
What this trial is testing

Effectiveness and Safety of Upadacitinib for Acute Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)Acute Severe Ulcerative ColitisUpadacitinib
Xijing Hospital of Digestive Diseases 81
Not applicableActive Not RecruitingNCT05081557
What this trial is testing

Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 873
Early research (Phase 1)Looking for participantsNCT07425899
What this trial is testing

The Safety and How the Body Processes ABBV-722 and Upadacitinib After Multiple Oral Doses in Healthy Adult Participants

Who this might be right for
Healthy Volunteer
AbbVie 32
Post-approval studies (Phase 4)Not Yet RecruitingNCT07502339
What this trial is testing

Upadacitinib in Patients Hospitalized With Acute Severe Ulcerative Colitis

Who this might be right for
UC - Ulcerative Colitis
University of California, San Francisco 50
Large-scale testing (Phase 3)Looking for participantsNCT06461897
What this trial is testing

Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 675
Not applicableActive Not RecruitingNCT05139836
What this trial is testing

Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World Setting

Who this might be right for
Atopic Dermatitis
AbbVie 634
Not applicableNot Yet RecruitingNCT06144567
What this trial is testing

Response to Upadacitinib of Enthesitis Evaluated by Ultrasound in Patients With Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 19
Large-scale testing (Phase 3)Study completedNCT02955212
What this trial is testing

A Study With Upadacitinib (ABT-494) in Subjects From China and Selected Countries With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 338
Not applicableStudy completedNCT07500467
What this trial is testing

Upadacitinib for Refractory Takayasu Arteritis

Who this might be right for
Takayasu Arteritis
Liu Tian 12
Early research (Phase 1)Looking for participantsNCT06379958
What this trial is testing

Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects

Who this might be right for
Pharmacokinetics
Modern Biosciences Ltd 48
Post-approval studies (Phase 4)Looking for participantsNCT07510191
What this trial is testing

TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With Suboptimal Response

Who this might be right for
Crohn Disease (CD)
Sixth Affiliated Hospital, Sun Yat-sen University 312
Not applicableLooking for participantsNCT05496348
What this trial is testing

Study of Oral Upadacitinib to Assess Change in Disease Activity in Adult Participants With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 400
Not applicableNot Yet RecruitingNCT07354906
What this trial is testing

Upadacitinib in Giant Cell Arteritis (GCA) With Active Large-vessel Involvement.

Who this might be right for
Giant Cell Arteritis (GCA)
Groupe français d'étude des Maladies Inflammatoires de loeil 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT07149467
What this trial is testing

Ustekinumab and Upadacitinib for Induction and Maintenance Therapy in Patients With Refractory Crohn's Disease: A Multicenter, Randomized, Parallel-Controlled Study

Who this might be right for
Crohn's Disease AggravatedCrohn's Disease in Remission
Sixth Affiliated Hospital, Sun Yat-sen University 454
Not applicableLooking for participantsNCT06581042
What this trial is testing

Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowel Disease in Belgium

Who this might be right for
Ulcerative ColitisCrohn's Disease
AbbVie 280
Large-scale testing (Phase 3)Study completedNCT03725202
What this trial is testing

Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis

Who this might be right for
Giant Cell Arteritis (GCA)
AbbVie 429
Large-scale testing (Phase 3)Looking for participantsNCT05609630
What this trial is testing

Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.

Who this might be right for
Juvenile Idiopathic Arthritis
AbbVie 90
Not applicableStudy completedNCT05029895
What this trial is testing

Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
AbbVie 167
Not applicableLooking for participantsNCT06454461
What this trial is testing

Efficacy of Upadacitinib After NECS in Vitiligo

Who this might be right for
Vitiligo
Jilin University 60
Large-scale testing (Phase 3)Study completedNCT03086343
What this trial is testing

Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 657
Load More Results